Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of CYH33 in patients with recurrent/persistent ovarian clear cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Clear Cell Carcinoma

Drugs mentioned

• CYH33

Snippet

Sponsor: Haihe Biopharma Co., Ltd. | Conditions: Ovarian Cancer, Recurrent Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING